KMB · Kimberly Clark Corp · Financials
$108.33
+2.92 (+2.77%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$35.06B
Shares
332.58M
Volume · Oct 20
5.1M
Avg daily vol (3M)
4.04M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$16.45B
-2.1%
FY2025
Net Income
$2.02B
-20.6%
FY2025
Gross Margin
36.01%
-1.4pp
FY2025
Operating Margin
14.29%
-1.8pp
FY2025
Diluted EPS
$6.07
-19.6%
FY2025
Operating Cash Flow
$2.78B
-14.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $16.58B | $16.45B | $16.81B | $17.15B | $20.18B | $19.44B | $19.14B | $18.45B | $18.49B | $18.35B | $18.29B | $18.59B | $19.72B | $19.56B | $19.47B | $20.85B | $19.75B | $19.12B | $19.42B | $18.27B | |
| $10.49B | $10.52B | $10.52B | $10.88B | $13.96B | $13.45B | $12.32B | $12.42B | $12.89B | $11.76B | $11.6B | $11.97B | $13.04B | $12.95B | $13.34B | $14.69B | $13.2B | $12.7B | $13.56B | $12.56B | |
| $6.1B | $5.92B | $6.29B | $6.27B | $6.22B | $5.99B | $6.82B | $6.04B | $5.6B | $6.59B | $6.69B | $6.62B | $6.68B | $6.61B | $6.13B | $6.15B | $6.55B | $6.42B | $5.86B | $5.7B | |
| — | 36.01% | 37.42% | 36.56% | 30.83% | 30.8% | 35.64% | 32.71% | 30.28% | 35.9% | 36.59% | 35.63% | 33.88% | 33.79% | 31.48% | 29.51% | 33.17% | 33.59% | 30.17% | 31.23% | |
| — | $326M | $328M | $303M | $292M | $269M | $276M | $284M | $317M | $309M | $326M | $324M | $368M | $333M | $335M | $316M | $317M | $301M | $297M | — | |
| — | $2M | $7M | $11M | $15M | $9M | $2M | $3M | — | — | — | — | — | $39M | $29M | $24M | — | — | — | — | |
| $725M | $805M | $781M | $753M | $754M | $766M | $796M | $917M | $882M | $724M | $705M | $746M | $862M | $863M | $857M | $1.09B | $813M | $783M | $775M | $807M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $434M | $415M | — | — | — | — | |
| $2.51B | $2.35B | $2.7B | $1.93B | $2.68B | $2.56B | $3.24B | $2.99B | $2.23B | $3.36B | $3.38B | $1.61B | $2.52B | $2.9B | $2.38B | $2.44B | $2.77B | $2.83B | $2.55B | $2.62B | |
| — | 14.29% | 16.07% | 11.24% | 13.29% | 13.17% | 16.95% | 16.21% | 12.06% | 18.3% | 18.5% | 8.68% | 12.78% | 14.84% | 12.21% | 11.71% | 14.04% | 14.78% | 13.12% | 14.32% | |
| $3.24B | $3.16B | $3.48B | $2.68B | $3.44B | $3.33B | $4.04B | $3.91B | $3.11B | $4.08B | $4.09B | $2.36B | $3.38B | $3.77B | $3.23B | $3.53B | $3.59B | $3.61B | $3.32B | $3.42B | |
| $236M | $256M | $270M | $293M | $282M | $256M | $252M | $261M | $263M | $318M | $319M | $295M | $284M | $282M | $285M | $277M | $243M | $275M | $304M | $265M | |
| $21M | $24M | $48M | $66M | $14M | $6M | $8M | $11M | $10M | $10M | $11M | $17M | $18M | $20M | $18M | $18M | $20M | $26M | $46M | $34M | |
| -$60M | -$67M | -$60M | -$96M | -$73M | -$86M | -$70M | -$91M | -$163M | -$59M | -$66M | — | — | — | — | — | — | — | — | — | |
| $213M | $196M | $216M | $196M | $116M | $98M | $142M | $123M | $103M | $104M | $132M | $149M | $146M | $205M | $177M | $161M | $181M | $164M | $166M | $170M | |
| $2.24B | $2.05B | $2.93B | $2.02B | $2.34B | $2.23B | $2.93B | $2.65B | $1.81B | $2.99B | $3.01B | $1.34B | $2.26B | $2.64B | $2.11B | $2.18B | $2.55B | $2.58B | $2.29B | $2.32B | |
| $733M | $599M | $442M | $343M | $495M | $479M | $676M | $576M | $471M | $776M | $922M | $418M | $856M | $828M | $660M | $660M | $788M | $746M | $618M | $537M | |
| $1.96B | $2.02B | $2.55B | $1.76B | $1.93B | $1.81B | $2.35B | $2.16B | $1.41B | $2.28B | $2.17B | $1.01B | $1.53B | $2.14B | $1.75B | $1.59B | $1.84B | $1.88B | $1.69B | $1.82B | |
| — | 12.29% | 15.14% | 10.29% | 9.59% | 9.33% | 12.29% | 11.69% | 7.63% | 12.42% | 11.84% | 5.45% | 7.74% | 10.95% | 8.99% | 7.63% | 9.33% | 9.86% | 8.7% | 9.98% | |
| $34M | $28M | $33M | $0 | $27M | $30M | $44M | $40M | $35M | $41M | $53M | $53M | $69M | $79M | $78M | $93M | $100M | $110M | $139M | $128M | |
| $2.08B | $2.34B | $2.36B | $1.85B | $1.51B | $1.75B | $2.47B | $2.16B | $1.19B | $2.83B | $1.97B | $1.06B | $448M | $1.96B | $1.56B | $1.19B | $2.21B | $2.47B | $95M | $2.46B | |
| USD/shares | $5.88 | $6.09 | $7.58 | $5.22 | $5.73 | $5.38 | $6.90 | $6.28 | $4.05 | $6.44 | $6.03 | $2.78 | $4.07 | $5.58 | $4.45 | $4.02 | $4.47 | $4.53 | $4.04 | $4.11 |
| USD/shares | $5.88 | $6.07 | $7.55 | $5.21 | $5.72G | $5.35G | $6.87G | $6.24 | $4.03 | $6.40 | $5.99 | $2.77 | $4.04 | $5.53 | $4.42 | $3.99 | $4.45 | $4.52 | $4.03 | $4.08 |
| shares | — | 331.9M | 335.6M | 337.8M | 337.4M | 337.3M | 340.7M | 343.6M | 348M | 353.6M | 359.4M | 363.8M | 374.5M | 384M | 393M | 395.7M | 412.4M | 416.1M | 418.5M | — |
| shares | — | 333.2M | 337M | 338.8M | 338.3M | 338.8M | 342.5M | 345.6M | 349.6M | 355.9M | 361.7M | 366.3M | 377.4M | 387.3M | 396.1M | 398.6M | 414.4M | 416.8M | 419.6M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $16.64B in buybacks, $24.8B in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Latest reported total
USD 7,100,000,000
As of Mar 31, 2026
Tracked instruments
0
Loans, facilities and note series
Annual baseline
Dec 31, 2025
Latest approved annual total
Reported total debt history
| As of | Reported label | Amount | Source |
|---|---|---|---|
| 2026-03-31 | total debt from continuing operations | USD 7,100,000,000 |
10-Q filed 2026-04-28
As of March 31, 2026 and December 31, 2025, total debt from continuing operations was $7.1 billion and $7.2 billion, respectively. |
| 2025-12-31 | Total debt from continuing operations | USD 7,200,000,000 |
10-Q filed 2026-04-28
As of March 31, 2026 and December 31, 2025, total debt from continuing operations was $7.1 billion and $7.2 billion, respectively. |
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current debt and lease obligations | 2026-06-30 | USD 43,000,000 | 10-Q filed 2026-08-04 |
| Noncurrent long-term debt and lease obligations | 2026-06-30 | USD 6,474,000,000 | 10-Q filed 2026-08-04 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.45×
Peer median 3.34×
EV/EBIT
16.16×
Peer median 25.89×
P/E (TTM)
17.93×
Peer median 35.19×
Peer medians compare against the 7 similar-size Household & Personal Products companies (of 30 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| North America (NA) | $10,753,000,000 | $11,017,000,000 | $10,996,000,000 | $10,470,000,000 | — | — | — | — |
| International Personal Care (IPC) | $5,694,000,000 | $5,743,000,000 | $5,940,000,000 | $6,054,000,000 | — | — | — | — |
| Consumer Tissue | — | — | $6,290,000,000 | $6,243,000,000 | $6,034,000,000 | $6,718,000,000 | $5,993,000,000 | $6,015,000,000 |
| International Family Care and Professional (IFP) | — | — | $3,544,000,000 | $3,651,000,000 | — | — | — | — |
| KC Professional | — | — | $3,404,000,000 | $3,256,000,000 | $3,072,000,000 | $3,019,000,000 | $3,292,000,000 | $3,382,000,000 |
| Personal Care | — | — | $10,691,000,000 | $10,622,000,000 | $10,267,000,000 | $9,339,000,000 | $9,108,000,000 | $9,037,000,000 |
| Corporate And Other | — | — | $46,000,000 | $54,000,000 | $67,000,000 | $64,000,000 | $57,000,000 | $52,000,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $10,100,000,000 | $10,400,000,000 | $10,400,000,000 | $9,800,000,000 | $9,285,000,000 | $9,679,000,000 | $9,027,000,000 | $8,803,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Babyandchildcareproducts | $6,773,000,000 | $7,056,000,000 | $7,054,000,000 | $7,166,000,000 | $7,200,000,000 | $6,400,000,000 | $6,300,000,000 | $6,300,000,000 |
| Family Care | $4,056,000,000 | $3,928,000,000 | $4,024,000,000 | — | — | — | — | — |
| Adult Care Products | $1,947,000,000 | $1,864,000,000 | $1,809,000,000 | $1,730,000,000 | — | — | — | — |
| Professional | $1,841,000,000 | $2,152,000,000 | $2,385,000,000 | — | — | — | — | — |
| Feminine Care Products | $1,706,000,000 | $1,721,000,000 | $1,787,000,000 | $1,695,000,000 | — | — | — | — |
| All Other | $124,000,000 | $84,000,000 | $87,000,000 | $85,000,000 | $3,100,000,000 | $3,000,000,000 | $2,900,000,000 | $2,800,000,000 |
| Away From Home Professional Products | — | — | — | $3,256,000,000 | $3,100,000,000 | $3,000,000,000 | $3,300,000,000 | $3,400,000,000 |
| Consumer Tissue Products | — | — | — | $6,243,000,000 | $6,000,000,000 | $6,700,000,000 | $6,000,000,000 | $6,000,000,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| North America (NA) | $2,553,000,000 | $2,542,000,000 | $2,514,000,000 | $2,110,000,000 | — | — | — | — |
| International Personal Care (IPC) | $796,000,000 | $826,000,000 | $673,000,000 | $670,000,000 | — | — | — | — |
| Consumer Tissue | — | — | $976,000,000 | $806,000,000 | $888,000,000 | $1,448,000,000 | $1,007,000,000 | $875,000,000 |
| International Family Care and Professional (IFP) | — | $377,000,000 | $287,000,000 | $256,000,000 | — | — | — | — |
| KC Professional | — | — | $665,000,000 | $457,000,000 | $404,000,000 | $528,000,000 | $657,000,000 | $634,000,000 |
| Personal Care | — | — | $1,890,000,000 | $1,787,000,000 | $1,856,000,000 | $1,933,000,000 | $1,904,000,000 | $1,833,000,000 |
| Corporate And Other | — | — | -$1,118,000,000 | -$412,000,000 | -$559,000,000 | -$719,000,000 | -$787,000,000 | -$1,112,000,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| North America (NA) | 23.7% | 23.1% | 22.9% | 20.2% | — | — | — | — |
| International Personal Care (IPC) | 14% | 14.4% | 11.3% | 11.1% | — | — | — | — |
| Consumer Tissue | — | — | 15.5% | 12.9% | 14.7% | 21.6% | 16.8% | 14.5% |
| International Family Care and Professional (IFP) | — | — | 8.1% | 7% | — | — | — | — |
| KC Professional | — | — | 19.5% | 14% | 13.2% | 17.5% | 20% | 18.7% |
| Personal Care | — | — | 17.7% | 16.8% | 18.1% | 20.7% | 20.9% | 20.3% |
| Corporate And Other | — | — | -2430.4% | -763% | -834.3% | -1123.4% | -1380.7% | -2138.5% |
Key facts
CIK
55785
CUSIP
494368103
13F (30d)
302 filings
278 filers
Visit website
Investor relations